Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy

Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

(2018) A. Bonertz et al.   ALLERGY

Reliability of a New Symptom Score in a Titrated Quantitative Conjunctival Provocation Test Supported by an Objective Photodocumentation

(2018) Oliver Pfaar et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Molecular fingerprinting of complex grass allergoids: size assessments reveal new insights in epitope repertoires and functional capacities

(2017) S. Starchenka et al.   World Allergy Organization Journal

A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients

(2016) O. Pfaar et al.   ALLERGY

Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies

(2016) Martin Rosewich et al.   Allergy Asthma & Immunology Research

Time-Based Measurement of Personal Mite Allergen Bioaerosol Exposure over 24 Hour Periods

(2016) Euan R. Tovey et al.   PLoS One

A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study

(2015) O. Pfaar et al.   ALLERGY

Conjunctival Provocation Tests: A Predictive Factor for Patients' Seasonal Allergic Rhinoconjunctivitis Symptoms

(2015) Kristian Kruse et al.   Journal of Allergy and Clinical Immunology-In Practice

Allergenic pollen season variations in the past two decades under changing climate in the United States

(2014) Yong Zhang et al.   GLOBAL CHANGE BIOLOGY

Clinical development success rates for investigational drugs

(2014) Michael Hay et al.   NATURE BIOTECHNOLOGY

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

(2013) A. Wesley Burks et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pollinex Quattro: An innovative four injections immunotherapy In allergic rhinitis

(2013) Martin Rosewich et al.   Human Vaccines & Immunotherapeutics

The placebo effect in allergen-specific immunotherapy trials

(2013) Annemie Narkus et al.   Clinical and Translational Allergy

Assessment of specific immunotherapy efficacy using a novel placebo score–based method

(2012) Anthony J. Frew et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Die Therapieallergene-Verordnung

(2012) L. Englert et al.   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz

European Academy of Allergy and Clinical Immunology task force report on ‘dose-response relationship in allergen-specific immunotherapy’

(2011) M. A. Calderón et al.   ALLERGY

Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen

(2011) Lawrence M. DuBuske et al.   ALLERGY AND ASTHMA PROCEEDINGS

Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI Collaborative Study

(2010) David I. Bernstein et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen

(2010) David Skoner et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY